Alelos; Artritis Psoriásica/genética; Predisposición Genética a la Enfermedad; Antígenos HLA/genética; Adulto; Estudios de Casos y Controles; Femenino; Frecuencia de los Genes; Haplotipos; Prueba de Histocompatibilidad; Humanos; Desequilibrio de Ligamiento; Masculino; Persona de Mediana Edad; Oportunidad Relativa; Adulto Joven

AS; CASP; CASPAR; CD; Collaborative Association Study of Psoriasis; DNA; EM; Expectation­Maximization; FBAT; FDR; GWAS; HLA; JIA; KIR; LD; MHC; NK; OR; PCA; PCR; PsA; SNP; SSO; SSP; SpA; WHO; World Health Organization; ankylosing spondylitis; classification criteria for psoriatic arthritis; cluster of differentiation; deoxyribonucleic acid; false discovery rate; family-based association test; genome-wide association study; human leukocyte antigen; juvenile idiopathic arthritis; killer-cell immunoglobulin-like receptors; linkage disequilibrium; major histocompatibility complex; natural killer; odds ratio; polymerase chain reaction; principal component analysis; psoriatic arthritis; sequence specific oligonucleotide; sequence specific primers; single nucleotide polymorphisms; spondyloarthritis